ASSESSMENT OF CLINICAL PROFILE AND TREATMENT CHART REVIEW FOR ALCOHOLIC LIVER DISEASE (ALD) PATIENTS: A PROSPECTIVE AND OBSERVATIONAL STUDY

Assessment of Alcoholic Liver Disease

  • Siddaruda Malleshappa Biradar Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India
  • Dhanavanti Gelada Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India
  • MV Mounika Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India
  • P Meghana Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India
  • M Bharathi Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India
  • Anand P. Ambali Department of Medicine, Shri B M. Patil Medical College Hospital and Research Centre, Vijaypur-586103, India
  • P Mallinath Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India
  • M Vinod Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India
  • NV Kalyane Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India

Abstract

Background/Aim: Alcohol remains one of most common cause of liver disease in India, hence the present study was undertaken to assess the clinical profile and treatment chart review of alcoholic liver disease (ALD) patients.


Materials and Methods: Hospital based prospective and observational study was carried out for a period of nine months in a tertiary care hospital of south India.  All the patients of either gender diagnosed with ALD were enrolled in the study and patient consent was taken, the data related to the patients of ALD were documented in a structured patient data collection form and analyzed carefully.


Results: ALD was mainly affected in male with age group of 41-50 years.Out of 130 patients 43.8% patients were suffered from Fatty Liver disease while 23.1% were suffered from Alcoholic Hepatitis and 33.1% were suffered from Cirrhosis of Liver. The secondary developments to ALD were portal hypertension (13.8%) followed by Ascities (10.8%) and Hepatitis (10%). The major risk factors involved in ALD was alcohol per se (52.3%) and, alcohol and smoking exaggerate the disease condition. The Periodic (61.5%) and regular basis (38.5%) of alcoholism for chronic period of time may land up with ALD. Polypharmacy is essential for the treatment of ALD as it inoved multiple secondary development to ALD. The patients were intervened and counselled on their individual basis for ALD consequences, and motivated for cessation of alcohol and smoking.


Conclusion: The study enlightens that the early diagnosis and its beneficial outcomes that can exponentially curtail the mortality rate of ALD. Similarly the optimal drug therapy regimen and patient counseling may improve the patient’s quality of life.


Keywords: Alcoholic Liver Disease; Optimal Drug Therapy; Patient Counselling; Improved Quality of Life

Downloads

Download data is not yet available.

Author Biographies

Siddaruda Malleshappa Biradar, Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India

Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India

Dhanavanti Gelada, Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India

Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India

MV Mounika, Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India

Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India

P Meghana, Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India

Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India

M Bharathi, Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India

Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India

Anand P. Ambali, Department of Medicine, Shri B M. Patil Medical College Hospital and Research Centre, Vijaypur-586103, India

Department of Medicine, Shri B M. Patil Medical College Hospital and Research Centre, Vijaypur-586103, India

P Mallinath, Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India

 Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India

M Vinod, Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India

 Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India

NV Kalyane, Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India

Department of Clinical Pharmacy Practice, SSM College of Pharmacy and Research Center, Vijaypur-586103, India

References

1. Frazier TH, Stocker AM, Kershner NA, Marsano LS, Mclain CJ. Treatment of alcoholic liver disease. Therapeutic Advances in Gastroenterology 2011; 4(1):63-81.
2. World Health Organization. WHO status report on alcohol 2011. 2011. Available at:http://www.who.int/substance_abuse/publications/global_alcohol_report/msbgsruprofiles.pdf?ua=1. Last accessed:18 November 2015.
3. Cirrhosis National Institute of Diabetes and Digestive and Kidney Diseases NIH.2014; 1114-1134.
4. Suthar H, Suthar K, Mewada B. Clinical Profiles of cases of Alcoholic Liver Disease.2013; 2:408-412.
5. The evidence base for alcohol guidelines, Royal College of Physicians 2011.
6. Marsano LS, Mendez C, Hill D , Barve S, McClain C J , Diagnosis and Treatment of Alcoholic Liver Disease and Its Complications. 2003; 27(3):247-256.
7. Ishii H, Horie Y, Yamagishi Y, Ebinuma H. Alcoholic Liver Disease and Its Relationship with Metabolic Syndrome, JMAJ 2010; 53(4):236–242.
8. Jamdadea VS, Malikb reddy CD, Ahkar MA, Kolatia SR, Prescription pattern of drugs and WHO prescribing indicators used in alcoholic liver disease in a tertiary care teaching hospital in north eastern INDIA. Int J Pharm Bio Sci., 2015; 6(4): 503 – 510.
9. Dugum M, Cullough AM. Diagnosis and Management of Alcoholic Liver Disease, Journal of Clinical and Translational Hepatology. 2015; 3:109–116.
10. Hogerzeil HV, Bimo, Ross-Degnan Det al. Field tests for rational drug use in twelve developing countries. Lancet 1993; 342(8884):1408-1410.
Statistics
35 Views | 89 Downloads
How to Cite
Biradar, S., Gelada, D., Mounika, M., Meghana, P., Bharathi, M., Ambali, A. P., Mallinath, P., Vinod, M., & Kalyane, N. (2018). ASSESSMENT OF CLINICAL PROFILE AND TREATMENT CHART REVIEW FOR ALCOHOLIC LIVER DISEASE (ALD) PATIENTS: A PROSPECTIVE AND OBSERVATIONAL STUDY. Journal of Drug Delivery and Therapeutics, 8(5), 437-441. https://doi.org/10.22270/jddt.v8i5.1945